TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

GROVECKLY

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

GROVECKLY

ST13

US500000088360445

Classe

5, 9, 10

Pedido

88360445

Registro

6203151

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

29

Atualização mais recente

25/11/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 9, 10

Data de depósito

28/03/2019

Data de registro

24/11/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

24/11/2020

Última transação

25/11/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

99

Localização do titular

Hellerup, DK

Examinador

LORENZO,GEORGE M

Unidade examinadora

L10

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Ascendis Pharma Endocrinology Division A/S

Representantes

Shannon Marie McKeon DYKEMA GOSSETT PLLC

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment infectious diseases; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases

Classe 9

Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases

Classe 10

Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

Publicações

Histórico de despachos e eventos da marca no USPTO.

29 publicações encontradas

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

24/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

24/11/2020

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

16/10/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

16/10/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

27/08/2020

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

27/08/2020

DOCK

ASSIGNED TO EXAMINER

04/06/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/04/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/02/2020

PUBO

PUBLISHED FOR OPPOSITION

11/02/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

22/01/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/01/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/01/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/01/2020

ALIE

ASSIGNED TO LIE

07/01/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

16/12/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

12/06/2019

GNSL

LETTER OF SUSPENSION E-MAILED

12/06/2019

CNSL

SUSPENSION LETTER WRITTEN

12/06/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

12/06/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/06/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

12/06/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/06/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/06/2019

GNRT

NON-FINAL ACTION E-MAILED

11/06/2019

CNRT

NON-FINAL ACTION WRITTEN

11/06/2019

DOCK

ASSIGNED TO EXAMINER

09/06/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

15/04/2019

NWAP

NEW APPLICATION ENTERED

01/04/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace GROVECKLY ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.